World’s first anti-ageing gene therapy trial begins as ER-100 is injected into a human eye, testing partial cellular reprogramming to restore vision and fight ageing ...

Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have ...

Pleased to announce the first patient has been dosed in our Phase 1 clinical trial, evaluating our lead candidate for optic ...

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be rejuvenated and potentially opening a new chapter in the science of aging.

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.

Aging—the progressive decline in our physiological function as we get older—is something many of us hope to slow, stop, or even reverse. Of course, this process is inevitable and something we cannot ...

Adani Mundra Airport has commenced scheduled commercial flight operations with Star Air's inaugural service from Goa. The ...

Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...

Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial will test a novel ...